Structural Basis for Inhibitor-Induced Hydrogen Peroxide Production by Kynurenine 3-Monooxygenase
- Authors
- Kim, Hyun Tae; Na, Byeong Kwan; Chung, Jiwoung; Kim, Sulhee; Kwon, Sool Ki; Cha, Hyunju; Son, Jonghyeon; Cho, Joong Myung; Hwang, Kwang Yeon
- Issue Date
- 19-4월-2018
- Publisher
- CELL PRESS
- Keywords
- drug design; flavin reduction; hydrogen peroxide; KMO inhibitor; kynurenine 3-monooxygenase
- Citation
- CELL CHEMICAL BIOLOGY, v.25, no.4, pp.426 - +
- Indexed
- SCIE
SCOPUS
- Journal Title
- CELL CHEMICAL BIOLOGY
- Volume
- 25
- Number
- 4
- Start Page
- 426
- End Page
- +
- URI
- https://scholar.korea.ac.kr/handle/2021.sw.korea/76115
- DOI
- 10.1016/j.chembiol.2018.01.008
- ISSN
- 2451-9448
- Abstract
- Kynurenine 3-monooxygenase (KMO) inhibitors have been developed for the treatment of neurodegenerative disorders. The mechanisms of flavin reduction and hydrogen peroxide production by KMO inhibitors are unknown. Herein, we report the structure of human KMO and crystal structures of Saccharomyces cerevisiae (sc) and Pseudomonas fluorescens (pf) KMO with Ro 61-8048. Proton transfer in the hydrogen bond network triggers flavin reduction in p-hydroxybenzoate hydroxylase, but the mechanism triggering flavin reduction in KMO is different. Conformational changes via pi-pi interactions between the loop above the flavin and substrate or non-substrate effectors lead to disorder of the C-terminal alpha helix in scKMO and shifts of domain III in pfKMO, stimulating flavin reduction. Interestingly, Ro 61-8048 has two different binding modes. It acts as a competitive inhibitor in scKMO and as a non-substrate effector in pfKMO. These findings provide understanding of the catalytic cycle of KMO and insight for structure-based drug design of KMO inhibitors.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Graduate School > Department of Biotechnology > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.